Search Within

Genitourinary Oncology Service

Formats
  1. Journal Article (2795)
  2. Meeting Abstract (2526)
  3. Review (121)
  4. Book Section (83)
  5. Editorial (57)
  6. Correspondence (34)
  7. Conference Paper (29)
  8. Guidelines (25)
  9. Research Letter (18)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Solid Tumor Oncology Division (5696)
  2. Department of Medicine (5686)
  3. GSK Faculty (1659)
  4. Human Oncology and Pathogenesis Program (1158)
  5. Department of Pathology and Laboratory Medicine (1130)
  6. Surgery (1021)

More Groups

People
  1. Robert Motzer (1252)
  2. Howard Scher (1133)
  3. David Solit (786)
  4. Dean Bajorin (664)
  5. Michael Morris (588)
  6. Jonathan Rosenberg (525)

More People

Years
  1. 2025 (204)
  2. 2024 (294)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1713)
  2. Annals of Oncology (304)
  3. Clinical Cancer Research (283)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (123)

More Publications

Publishers
  1. American Society of Clinical Oncology (1780)
  2. American Association for Cancer Research (690)
  3. Oxford University Press (414)
  4. Elsevier Science, Inc. (396)
  5. Elsevier Inc. (380)
  6. Nature Publishing Group (304)

More Publishers

Results (5696)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Periprostatic adipose inflammation is associated with high-grade prostate cancer
    Journal Article

    Gucalp, A.; Iyengar, N. M.; Zhou, X. K.; Giri, D. D.; Falcone, D. J.; Wang, H.; Williams, S.; Krasne, M. D.; Yaghnam, I.; Kunzel, B.; more...
    Prostate Cancer and Prostatic Diseases (2017)

    Fulltext@MSK | Save
  • First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): A multicentre, single-arm, phase 2 study
    Journal Article

    Balar, A. V.; Castellano, D.; O'Donnell, P. H.; Grivas, P.; Vuky, J.; Powles, T.; Plimack, E. R.; Hahn, N. M.; de Wit, R.; Pang, L.; more...
    Lancet Oncology (2017)

    Fulltext@MSK | Save
  • Is the evidence sufficient to recommend statins for all men with prostate cancer?
    Journal Article

    Mucci, L. A.; Kantoff, P. W.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Practice makes perfect: The rest of the story in testicular cancer as a model curable neoplasm
    Journal Article

    Tandstad, T.; Kollmannsberger, C. K.; Roth, B. J.; Jeldres, C.; Gillessen, S.; Fizazi, K.; Daneshmand, S.; Lowrance, W. T.; Hanna, N. H.; Albany, C.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Clinical and genome-wide analysis of cisplatin-induced peripheral neuropathy in survivors of adult-onset cancer
    Journal Article

    Dolan, M. E.; Charif, O. E.; Wheeler, H. E.; Gamazon, E. R.; Ardeshir-Rouhani-Fard, S.; Monahan, P.; Feldman, D. R.; Hamilton, R. J.; Vaughn, D. J.; Beard, C. J.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO guideline
    Journal Article

    Chang, S. S.; Bochner, B. H.; Chou, R.; Dreicer, R.; Kamat, A. M.; Lerner, S. P.; Lotan, Y.; Meeks, J. J.; Michalski, J. M.; Morgan, T. M.; more...
    Journal of Urology (2017)

    Fulltext@MSK | Save
  • A phase II study of atezolizumab (atezo) with or without bevacizumab (bev) vs sunitinib (sun) in untreated metastatic renal cell carcinoma (mRCC) patients (pts)
    Meeting Abstract

    Grünwald, V.; McDermott, D. F.; Atkins, M.; Motzer, R.; Rini, B.; Escudier, B.; Fong, L.; Joseph, R.; Pal, S. K.; Sznol, M. M. D.; more...
    Oncology Research and Treatment (2017)

    Fulltext@MSK | Save
  • Atezolizumab (atezo) in platinum-treated locally advanced or metastatic urothelial carcinoma (mUC): Outcomes by prior therapy
    Meeting Abstract

    v. Amsberg, G.; Perez-Garcia, J. L.; Loriot, Y.; Rosenberg, J. E.; Powles, T.; Necchi, A.; Hussain, S. A.; Morales-Barrera, R.; Retz, M.; Niegisch, G.; more...
    Oncology Research and Treatment (2017)

    Fulltext@MSK | Save
  • Potential impact of avelumab + axitinib (A + Ax) on tumor size (TS) compared with historical data of sunitinib (S) as evaluated by a modeling and simulation (MS) approach
    Meeting Abstract

    Zheng, J.; Chang, A.; Larkin, J.; Motzer, R. J.; Amantea, M.; Bello, C.; Pavlov, D.; Geraldes, M.; Martignoni, M.; Di Pietro, A.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Adjuvant sunitinib (SU) in patients (pts) with high risk renal cell carcinoma (RCC): Safety and therapy management in S-TRAC trial
    Meeting Abstract

    Staehler, M.; Motzer, R. J.; George, D. J.; Pandha, H. S.; Donskov, F.; Escudier, B.; Kliment, J.; Pantuck, A. J.; Patel, A.; Deannuntis, L.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save